Evidence map›Paper›PMID 33262242›Full record

ArticlemSystems2020

PerSort Facilitates Characterization and Elimination of Persister Subpopulation in Mycobacteria.

Vivek Srinivas, Mario L Arrieta-Ortiz, Amardeep Kaur, Eliza J R Peterson, Nitin S Baliga

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.3field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Vivek SrinivasInstitute for Systems Biology, Seattle, Washington, USA.
Mario L Arrieta-OrtizInstitute for Systems Biology, Seattle, Washington, USA.
Amardeep KaurInstitute for Systems Biology, Seattle, Washington, USA.
Eliza J R PetersonInstitute for Systems Biology, Seattle, Washington, USA Eliza.Peterson@isbscience.org nitin.baliga@isbscience.org.ORCID https://orcid.org/0000-0003-2934-5267
Nitin S BaligaInstitute for Systems Biology, Seattle, Washington, USA Eliza.Peterson@isbscience.org nitin.baliga@isbscience.org.ORCID https://orcid.org/0000-0001-9157-5974
Institute for Systems Biology · USLawrence Berkeley National Laboratory · US

Funding

Technology CoreU19AI135976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADEREM, ALAN A · 2018 to 2022
$17.0M
A systems analysis of drug tolerance in Mycobacterium tuberculosisR01AI128215 · NIAID · INSTITUTE FOR SYSTEMS BIOLOGY · PI Nitin S Baliga · 2017 to 2026
$8.8M
NIAID NIH HHS R01 AI128215NIAID NIH HHS U19 AI135976
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic toleranceMycobacteriumnutrient starvationpersistersphenotypic heterogeneity

Identifiers

PMID33262242
PMCPMC7716392
OpenAlexW3109022664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.